PEPE II - A multicenter study with an end-point heparin-bonded expanded polytetrafluoroethylene vascular graft for above and below knee bypass surgery: Determinants of patency

Journal of Cardiovascular Surgery

Volumn 50, Issue 2, 2009, Pages 195-203

  Hugl, B ^a   Nevelsteen, A ^b   Daenens, K ^b   Alonso Perez, M ^c   Heider, P ^d   Railo, M ^e   Schelzig, H ^f   Gluecklich, B ^g   Balzer, K ^h   Vermassen, F ⁱ   De Smit, P ^j   Fraedrich, G ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f UNIVERSITY OF ULM   (Germany)

^g Department of Thoracic and Vascular Surgery   (Germany)

^h EVANGELISCHES KRANKENHAUS   (Germany)

ⁱ GHENT UNIVERSITY HOSPITAL   (Belgium)

^j MEDISCH SPECTRUM TWENTE   (Netherlands)

more..

Author keywords

Graft occlusion, vascular; Peripheral vascular diseases; Polytetra fluoroethylene

Indexed keywords

HEPARIN;

ARTERY DISEASE; ARTICLE; BLEEDING; BYPASS SURGERY; CLINICAL TRIAL; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; GRAFT INFECTION; GROUPS BY AGE; HEART INFARCTION; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; KNEE SURGERY; METHODOLOGY; MULTICENTER STUDY; POLITEF IMPLANT; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; SEROMA; SEX DIFFERENCE; SURGICAL PATIENT; THROMBECTOMY; THROMBOSIS; TIBIA; VASCULAR PATENCY; VASCULAR SURGERY; WOUND HEALING IMPAIRMENT;

AGED; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; EUROPE; FEMALE; FIBRINOLYTIC AGENTS; GRAFT OCCLUSION, VASCULAR; HEPARIN; HUMANS; KNEE; MALE; POLYTETRAFLUOROETHYLENE; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; REOPERATION; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 67650467300     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Veith FJ, Gupta SK, Ascer E, White-Flores S, Samson RH, Scher LA et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetraflourethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 1986;3:104-114 (Pubitemid 16186498)
2. Dorrucci V. Treatment of superficial femoral artery occlusive disease. J Cardiovasc Surg 2004;45:193-201. (Pubitemid 39069799)
3. Albers M, Battistella M, Romiti VM, Rodrigues M, Pereira CA. Meta-analysis of polytetrafluoroethylene bypass grafts to infrapopliteal arteries. J Vasc Surg 2003;37:1263-1269 (Pubitemid 41123104)
4. Dorigo W, Di Carlo F, Troisi N, Pratesi G, Alessi Innocenti A, Pulli R et al. Lower limb revascularization with a new bioactive prosthetic graft: early and late results. Ann Vasc Surg 2008;22:79-87.
5. Begovac PC, Thomson RC, Fisher JL, Hugson A, Gallhagen A. Improvements in GORE-TEX vascular graft performance by Carmeda bioactive surface heparin immobilization. Eur J Vasc Endovasc Surgery 2003;25:432-437 (Pubitemid 36603293)
6. Klinkert P, Schepers A, Burger D, van Bockel JH, Breslau PJ. Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: Five-year results of a randomized controlled trial. J Vasc Surg 2003;37:149-155 (Pubitemid 36236959)
7. Bosiers M, Deloose K, Verbist J, Schroë H, Lauwers G, Lansink W et al. Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoropopliteal and femorocrural bypass grafting: 1-year results. J Vasc Surg 2006;43:313-319 (Pubitemid 43221926)
8. Lin PH, Bush RL, Yao Q, Lumsden AB, Chen C. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model. J Surgical Research 2004;118:45-52. (Pubitemid 38490515)
9. Lin Ph, Chen C, Bush RL, Yao Q, Lumsden AB, Hanson SR. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model. J Vasc Surg 2004;39:1322-1328 (Pubitemid 38952603)
10. Taylor LM Jr, Edwards JM, Porter JM. Present status of reversed vein bypass grafting: five-year results of a modern series. J Vasc Surg 1990;11:193-205. (Pubitemid 20063925)
11. Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, Harrington DP. Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease. Med Decis Making 1994;14:71-78 (Pubitemid 24137118)
12. McCollum CN, Kenchington G, Alexander C, Franks P, Greenhalgh RM, and the Femoro-Popliteal Bypass Trial participants. PTFE or HUV for femoro-popliteal bypass: a multicenter trial. Eur J Vasc Surg 1991;5:435-443
13. Johnson WC, Lee KK. A comparative evaluation of PTFE, umbilical vein and saphenous vein bypass grafts for femoropopliteal above-knee revascularization: a prospective randomized Department of Veterans Affaires cooperative study. J Vasc Surgery 2000;32:268-277 (Pubitemid 30644940)
14. Ritter EF, Kim YB, Reischl HP, Serafin D, Rudner AM, Klitzman B. Heparin coating of vascular protheses reduces thromboemboli. Surgery 1997;122:888-892 (Pubitemid 27495929)
15. Lambert AW, Fox AD, Williams DJ, Horrocks M, Budd JS. Experience with heparin-bonded collagen-coated grafts for infrainguinal bypass. Cardiovasc Surg 1999;7:491-494 (Pubitemid 29349663)
16. Devine C, Hons B, McCollum C. Heparin-bonded Dacron or polytetrafuoroethylene for femoropopliteal bypass grafting: a multicenter trial. J Vasc Surg 2001;33:533-539 (Pubitemid 32215603)
17. Devine C, McCollum C, North West Femoro-Popliteal Trial Participants. Heparin-bonded Dacron or polytetrafuoroethylene for femoropopliteal bypass grafting: five-year results of a prospective randomized multicenter clinical trial. J Vasc Surg 2004;40:924-31. (Pubitemid 39535222)
18. Walluscheck KP, Bierkandt S, Brandt M, Cremer J. Infragenuinal ePTFE vascular graft with bioactive surface heparin bonding. First clinical results. J Cardiovasc Surg 2005;46:425-430 (Pubitemid 41582232)
19. Dorigo W, Pulli R, Alessi Innocenti A, Pratesi G, Innocenti AA, Pulli R et al. Lower limb below-knee revascularization with a new bioactive prosthetic graft: a case-control study. Ital J Vasc Endovasc Surg 2005;12:75-81. (Pubitemid 41702612)
20. Ballotta E, Renon L, Toffano M, Da Giau G. Prospective randomized study on bilateral above-knee femoropopliteal revascularization: Polytetrafluoroethylene graft versus reversed saphenous vein. J Vasc Surg 2003;38:1051-1055 (Pubitemid 37409642)
21. Green RM, Abbott WM, Matsumoto T, Wheeler JR, Miller N, Veith FJ et al. Prosthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trial. J Vasce Surg 2000;31:417-425 (Pubitemid 30158002)
22. Curi MA, Skelly CL, Meyerson SL, Woo DH, Desai TR, McKinsey JK et al. Conduit of choice for above-knee femoropopliteal bypass grafting in patients with limb-threatening ischemia. Ann Vasc Surg 2002;16:95-101. (Pubitemid 34194611)
23. Hanke M, Wolf O, Heider P. Kniegelenksüberschreitende Bypässe im Stadium der chronischen kritischen Ischämie: Ergebnisse und Offenheitsraten des Patientengutes der Jahre 1994-1999. Gefchir 2003;8:41-45
24. Dorrucci V, Griselli F, Petralia G, Spinamano L, Adornetto R. Heparin-bonded expanded polytetrafluoroethylene grafts for infragenicular bypass in patients with critical limb ischemia: 2-year results. J Cardiovasc Surg (Torino) 2008;49:145-149 (Pubitemid 351833233)
25. Peeters P, Verbist J, Deloose K, Bosiers M. Will heparin-bonded PTFE replace autologous conduits in infrapopliteal Bypass? J Vasc Endovasc Surg 2008;15:143-148
26. Reilly CF, Kindy MS, Brown KE, Rosenberg RD, Sonenshein GE. Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle. J Biol Chem 1989;264:6990-6995 (Pubitemid 19114815)
27. Castellot JJ Jr, Wong K, Herman B, Hoover RL, Albertini DF, Kaisee WJ et al. Binding and internalization of heparin by smooth muscle cells. J Cell Physiol 1985;124:13-20. (Pubitemid 15042633)